You are here
Synthesis & Characterization of a Tuberculosis Vaccine
Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R43AI056880-01A1
Agency Tracking Number: AI056880
Amount:
$133,000.00
Phase:
Phase I
Program:
SBIR
Solicitation Topic Code:
N/A
Solicitation Number:
PHS2004-2
Timeline
Solicitation Year:
2004
Award Year:
2004
Award Start Date (Proposal Award Date):
N/A
Award End Date (Contract End Date):
N/A
Small Business Information
ANCORA PHARMACEUTICALS
700 HURON AVE, #18K
CAMBRIDGE, MA
02138
United States
DUNS:
N/A
HUBZone Owned:
No
Woman Owned:
No
Socially and Economically Disadvantaged:
No
Principal Investigator
Name: OBADIH Plante
Phone: (781) 395-7700
Email: OPLANTE@ANCORAPHARMA.COM
Phone: (781) 395-7700
Email: OPLANTE@ANCORAPHARMA.COM
Business Contact
Name: JOHN PENA
Phone: (617) 354-0863
Email: JPENA@ANCORAPHARMA.COM
Phone: (617) 354-0863
Email: JPENA@ANCORAPHARMA.COM
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): Tuberculosis (TB) has plagued mankind for millennia. While several drugs and vaccine strategies have been developed to counter the TB, it remains a major infectious cause of morbidity and mortality worldwide. 1.Thoug
* Information listed above is at the time of submission. *